HIV

ViiV Healthcare announces FDA approval of an expanded indication for Dovato (dolutegravir/lamivudine), a complete two-drug regimen for virologically suppressed adults with HIV-1

By
1 Mins read
98
0
Share
Reading Time: < 1 minute

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced Read More

98
0
Share
Related posts
HIV

South African NGOs worry Trump's aid freeze will cause HIV patients to default on treatment

By
1 Mins read
Reading Time: < 1 minute At a rural village in South Africa’s KwaZulu-Natal province, unemployed 19-year-old Nozuko Majola is trying to figure out if she has enough money for…
HIV

'My wife fears sex, I fear death' - impacts of the USAID freeze

By
1 Mins read
Reading Time: < 1 minute Life for Mike Elvis Tusubira, a motorcycle taxi rider with HIV in Uganda, has been turned upside down since US President Donald…
HIV

HIV infections could jump over 6 times if US support is dropped and not replaced, UNAIDS chief says

By
1 Mins read
Reading Time: < 1 minute The head of the U.N. AIDS agency said Monday the number of new HIV infections could jump more than six times by 2029…
Subscribe to our Blog

Let's stay in touch. Subscribe to our blog and get our best content in your inbox. 

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.